Health Tools

Blood Pressure Calculator

Child Growth

Creatinine Calculator

Water Intake

Parkland Formula

CHD RISK

Hygiene

Introduction

Daily Hygiene

Dental Hygiene

Human Hygiene

Food Safety

Proper Handwash

Naturopathy

Naturopathy Introduction

Detoxification And Cleansing

Panchakarma

Naturopathy Counseling

Mental health

Mental health Introduction

ADHD

OCD

Schizophrenia

Medication

CHD RISK

Prostate Cancer - New Genetic Risk Factors

London, Feb 11 (ANI): British and Australian scientists have achieved a major genetic breakthrough in the understanding of prostate cancer, paving the way for new tests and treatments for the disease.

The scientists say that they have found seven new sites in the human genome that are linked to a man’s risk of developing prostate cancer.

According to them, their discovery may pave the way for treatments targeting specific genes, and a much-needed screening test for the disease.

The scientists say that each of the genetic alterations their latest study has revealed may increase a man’s chances of developing prostate cancer by up to 60 per cent.

Although they called their findings exciting, they clarified that more research was needed before they were translated into benefits for patients.

A group of scientists led by Dr. Ros Eeles examined the genetic makeup of more than 10,000 men as part of the study, which was supported by Cancer Research UK.

The scientists came to the conclusion that a gene known as MSMB could be used in prostate prostate cancer screening and disease monitoring The scientists came to the conclusion that a gene known as MSMB could be used in prostate cancer screening and disease monitoring based on their observations. They also discovered a different region of the genome that contains the gene LMTK2, which might serve as a brand-new therapeutic target.

The development of prostate cancer is thought to be influenced by a variety of factors, and certain gene combinations may significantly contribute to the disease, according to scientists.

The new study, according to the research team, contains the greatest number of genetic risk factors forprostate cancer to date.

These encouraging findings could improve targeted screening and treatment as well as help us determine the risk of developing prostate prostate cancer more precisely. The Scotsman quoted Eeles as saying in Nature Genetics that genetic profiling would actually target who should receive screening and what kind of care they should receive.

Professor Doug Easton, director of Cancer Research UK’s genetic epidemiology unit at the University of Cambridge, said: “In comparison with other cancers, such as breast and lung cancer, we understand little about how prostate cancer develops. These results will greatly improve our knowledge of this important disease.

The new research would improve our understanding of the condition, but Dr. Chris Hiley, from the prostate cancer charity, cautioned that it might take some time before any practical benefits appeared.